Back to Journals » Clinical Ophthalmology » Volume 2 » Issue 4

Hypoxia-ischemia and retinal ganglion cell damage

Authors Kaur C, Foulds WS, Ling E-A

Published 5 December 2008 Volume 2008:2(4) Pages 879—889


Review by Single-blind

Peer reviewer comments 3

Charanjit Kaur1, Wallace S Foulds2, Eng-Ang Ling1

1Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; 2Singapore Eye Research Institute, Singapore

Abstract: Retinal hypoxia is the potentially blinding mechanism underlying a number of sight-threatening disorders including central retinal artery occlusion, ischemic central retinal vein thrombosis, complications of diabetic eye disease and some types of glaucoma. Hypoxia is implicated in loss of retinal ganglion cells (RGCs) occurring in such conditions. RGC death occurs by apoptosis or necrosis. Hypoxia-ischemia induces the expression of hypoxia inducible factor-1α and its target genes such as vascular endothelial growth factor (VEGF) and nitric oxide synthase (NOS). Increased production of VEGF results in disruption of the blood retinal barrier leading to retinal edema. Enhanced expression of NOS results in increased production of nitric oxide which may be toxic to the cells resulting in their death. Excess glutamate release in hypoxic-ischemic conditions causes excitotoxic damage to the RGCs through activation of ionotropic and metabotropic glutamate receptors. Activation of glutamate receptors is thought to initiate damage in the retina by a cascade of biochemical effects such as neuronal NOS activation and increase in intracellular Ca2+ which has been described as a major contributing factor to RGC loss. Excess production of proinflammatory cytokines also mediates cell damage. Besides the above, free-radicals generated in hypoxic-ischemic conditions result in RGC loss because of an imbalance between antioxidant- and oxidant-generating systems. Although many advances have been made in understanding the mediators and mechanisms of injury, strategies to improve the damage are lacking. Measures to prevent neuronal injury have to be developed.

Keywords: retinal hypoxia, retinal ganglion cells, glutamate receptors, neuronal injury, retina

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Anti-inflammatory effects of budesonide in human lung fibroblasts are independent of histone deacetylase 2

Wang X, Nelson A, Weiler ZM, Patil A, Sato T, Kanaji N, Nakanishi M, Michalski J, Farid M, Basma H, LeVan TD, Miller-Larsson A, Wieslander E, Muller KC, Holz O, Magnussen H, Rabe KF, Liu X, Rennard SI

Journal of Inflammation Research 2013, 6:109-119

Published Date: 20 August 2013

Cost effectiveness of a telephone intervention to promote dilated fundus examination in adults with diabetes mellitus

Clyde B Schechter, Charles E Basch, Arlene Caban, Elizabeth A Walker

Clinical Ophthalmology 2008, 2:763-768

Published Date: 5 December 2008

A comparison of pneumolysin activity and concentration in vitro and in vivo in a rabbit endophthalmitis model

Melissa E Sanders, Erin W Norcross, Quincy C Moore III, Chinwendu Onwubiko, Lauren B King, et al

Clinical Ophthalmology 2008, 2:793-800

Published Date: 5 December 2008

Viscoless microincision cataract surgery

Guy Sallet

Clinical Ophthalmology 2008, 2:717-721

Published Date: 5 December 2008

Increased expression of IRE1α and stress-related signal transduction proteins in ischemia-reperfusion injured retina

Natsuyo Hata, Toshiyuki Oshitari, Akiko Yokoyama, Yoshinori Mitamura, Shuichi Yamamoto

Clinical Ophthalmology 2008, 2:743-752

Published Date: 5 December 2008

Bacterial endophthalmitis following 25-gauge transconjunctival sutureless vitrectomy

Drew N Sommerville, Dean P Hainsworth

Clinical Ophthalmology 2008, 2:935-936

Published Date: 5 December 2008

Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review

Andrea Russo, Ivano Riva, Teodoro Pizzolante, Federico Noto, Luciano Quaranta

Clinical Ophthalmology 2008, 2:897-905

Published Date: 5 December 2008

Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy

Ashraf M El-Batarny

Clinical Ophthalmology 2008, 2:709-716

Published Date: 5 December 2008